{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:17:36Z","timestamp":1790939856380,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.virol.2005.08.040","type":"journal-article","created":{"date-parts":[[2005,10,15]],"date-time":"2005-10-15T07:10:54Z","timestamp":1129360254000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["DNA immunization using a non-viral promoter"],"prefix":"10.1016","volume":"344","author":[{"given":"T.","family":"Vanniasinkam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.J.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.08.040_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1281.005","article-title":"Modulation of Toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA","volume":"1002","author":"Agrawal","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5164","key":"10.1016\/j.virol.2005.08.040_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.virol.2005.08.040_bib3","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1128\/jvi.63.7.2885-2892.1989","article-title":"Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein","volume":"63","author":"Ertl","year":"1989","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2005.08.040_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2005.08.040_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/viro.1993.1591","article-title":"Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription","volume":"197","author":"Gribaudo","year":"1993","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.virol.2005.08.040_bib6","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1128\/MCB.20.17.6185-6194.2000","article-title":"Class II transactivator: mastering the art of major histocompatibility complex expression","volume":"20","author":"Harton","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"6813","key":"10.1016\/j.virol.2005.08.040_bib7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.virol.2005.08.040_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/jir.1992.12.237","article-title":"The antiviral effects of the interferons and their inhibition","volume":"12","author":"Kerr","year":"1992","journal-title":"J. Interf. Res."},{"key":"10.1016\/j.virol.2005.08.040_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.immunol.14.1.301","article-title":"Regulation of MHC class II genes: lessons from a disease","volume":"14","author":"Mach","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.virol.2005.08.040_bib10","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/MCB.22.13.4781-4791.2002","article-title":"Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation","volume":"22","author":"Morris","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.virol.2005.08.040_bib11","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/emboj\/16.10.2851","article-title":"Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA","volume":"16","author":"Muhlethaler-Mottet","year":"1997","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.virol.2005.08.040_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(00)80468-9","article-title":"Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1","volume":"8","author":"Muhlethaler-Mottet","year":"1998","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.virol.2005.08.040_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0264-410X(96)00247-2","article-title":"Development of improved vectors for DNA-based immunization and other gene therapy applications","volume":"15","author":"Norman","year":"1997","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virol.2005.08.040_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.171.4.1999","article-title":"DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells","volume":"171","author":"Oran","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.virol.2005.08.040_bib15","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4049\/jimmunol.169.3.1326","article-title":"Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator","volume":"169","author":"Pai","year":"2002","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.virol.2005.08.040_bib16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.gt.3300964","article-title":"The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector","volume":"6","author":"Pasquini","year":"1999","journal-title":"Gene Ther."},{"issue":"12","key":"10.1016\/j.virol.2005.08.040_bib17","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.4049\/jimmunol.171.12.6774","article-title":"Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers","volume":"171","author":"Pinto","year":"2003","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.virol.2005.08.040_bib18","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/hum.1997.8.17-2019","article-title":"Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression","volume":"8","author":"Qin","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"2","key":"10.1016\/j.virol.2005.08.040_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymthe.2003.11.008","article-title":"CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses","volume":"9","author":"Reyes-Sandoval","year":"2004","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.virol.2005.08.040_bib20","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1128\/jvi.71.7.4892-4903.1997","article-title":"Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag\/protease and particle formation","volume":"71","author":"Schneider","year":"1997","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2005.08.040_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0092-8674(05)80090-X","article-title":"Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)","volume":"75","author":"Steimle","year":"1993","journal-title":"Cell"},{"issue":"5168","key":"10.1016\/j.virol.2005.08.040_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","article-title":"Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA","volume":"265","author":"Steimle","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.08.040_bib23","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0092-8674(02)00696-7","article-title":"Genetic control of MHC class II expression","volume":"109","author":"Ting","year":"2002","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.virol.2005.08.040_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2004.04.011","article-title":"The immunobiology of the TLR9 subfamily","volume":"25","author":"Wagner","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virol.2005.08.040_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.1995.tb44732.x","article-title":"DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response","volume":"772","author":"Whalen","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.virol.2005.08.040_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1074-7613(95)80001-8","article-title":"Manipulation of the immune response to a Plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines","volume":"2","author":"Xiang","year":"1995","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.virol.2005.08.040_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1994.1105","article-title":"Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus","volume":"199","author":"Xiang","year":"1994","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.virol.2005.08.040_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.virol.2005.08.040_bib29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0264-410X(96)00269-1","article-title":"The effect of interferon-gamma on genetic immunization","volume":"15","author":"Xiang","year":"1997","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.virol.2005.08.040_bib30","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1128\/MCB.20.16.6051-6061.2000","article-title":"Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter","volume":"20","author":"Zhu","year":"2000","journal-title":"Mol. Cell. Biol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500560X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268220500560X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:40:12Z","timestamp":1758584412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268220500560X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S004268220500560X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.08.040","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA immunization using a non-viral promoter","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}